Paper28512353
Favorable Response to Long-term Nucleos(t)ide Analogue Therapy in HBeAg-positive Patients with High Serum Fucosyl-Agalactosyl IgG.
Ho CH and 10 others. Sci Rep, 2017. Cited by 5 papers, by iCite.
Cite this record
ConductScience Library. Favorable Response to Long-term Nucleos(t)ide Analogue Therapy in HBeAg-positive Patients with High Serum Fucosyl-Agalactosyl IgG. Papers, record 28512353. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/28512353
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Favorable Response to Long-term Nucleos(t)ide Analogue Therapy in HBeAg-positive Patients with High Serum Fucosyl-Agalactosyl IgG.
- PubMed
Topics15
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Antiviral Agents | Major topic |
| Hepatitis B e Antigens | Major topic |
| Hepatitis B virus | Major topic |
| Hepatitis B, Chronic | Major topic |
| Immunoglobulin G | Major topic |
| Nucleosides | Major topic |
| Biomarkers | |
| Drug Resistance, Viral | |
| Female | |
| Humans | |
| Male | |
| Proportional Hazards Models | |
| ROC Curve | |
| Treatment Outcome | |
| Glycoproteins |
Source PubMed
References34
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 21372248 | Fc-glycosylation of IgG1 is modulated by B-cell stimuli. | Mol Cell Proteomics | 2011 | https://conductscience.org/library/papers/21372248 | PubMed |
| 2 | 21718667 | Hepatitis B surface antigen quantification: why and how to use it in 2011 - a core group report. | J Hepatol | 2011 | https://conductscience.org/library/papers/21718667 | PubMed |
| 3 | 25178562 | Hepatitis B flares in chronic hepatitis B: pathogenesis, natural course, and management. | J Hepatol | 2014 | https://conductscience.org/library/papers/25178562 | PubMed |
| 4 | 7743660 | Antibody-directed complement-mediated cytotoxicity to hepatocytes from patients with chronic hepatitis B. | Clin Exp Immunol | 1995 | https://conductscience.org/library/papers/7743660 | PubMed |
| 5 | 24445665 | The function of Fcγ receptors in dendritic cells and macrophages. | Nat Rev Immunol | 2014 | https://conductscience.org/library/papers/24445665 | PubMed |
| 6 | 8016124 | Agalactosyl glycoforms of IgG autoantibodies are pathogenic. | Proc Natl Acad Sci U S A | 1994 | https://conductscience.org/library/papers/8016124 | PubMed |
| 7 | 26566064 | AASLD guidelines for treatment of chronic hepatitis B. | Hepatology | 2016 | https://conductscience.org/library/papers/26566064 | PubMed |
| 8 | 25808668 | Re-evaluation of hepatitis B virus clinical phases by systems biology identifies unappreciated roles for the innate immune response and B cells. | Hepatology | 2015 | https://conductscience.org/library/papers/25808668 | PubMed |
| 9 | 18039107 | Immunobiology and pathogenesis of viral hepatitis. | Annu Rev Pathol | 2006 | https://conductscience.org/library/papers/18039107 | PubMed |
| 10 | 15994813 | Mannose binding lectin genotypes influence recovery from hepatitis B virus infection. | J Virol | 2005 | https://conductscience.org/library/papers/15994813 | PubMed |
| 11 | 24373085 | HBsAg quantification: useful for monitoring natural history and treatment outcome. | Liver Int | 2014 | https://conductscience.org/library/papers/24373085 | PubMed |
| 12 | 23905813 | Impact of therapy on the long-term outcome of chronic hepatitis B. | Clin Liver Dis | 2013 | https://conductscience.org/library/papers/23905813 | PubMed |
| 13 | 19714720 | Chronic hepatitis B: update 2009. | Hepatology | 2009 | https://conductscience.org/library/papers/19714720 | PubMed |
| 14 | 20628345 | Hepatocellular carcinoma: A global view. | Nat Rev Gastroenterol Hepatol | 2010 | https://conductscience.org/library/papers/20628345 | PubMed |
| 15 | 17393513 | Management of hepatitis B: summary of a clinical research workshop. | Hepatology | 2007 | https://conductscience.org/library/papers/17393513 | PubMed |
| 16 | 12154377 | Roles of Fc receptors in autoimmunity. | Nat Rev Immunol | 2002 | https://conductscience.org/library/papers/12154377 | PubMed |
| 17 | 25529092 | HBsAg quantification to optimize treatment monitoring in chronic hepatitis B patients. | Liver Int | 2015 | https://conductscience.org/library/papers/25529092 | PubMed |
| 18 | 15738952 | Immunology of hepatitis B virus and hepatitis C virus infection. | Nat Rev Immunol | 2005 | https://conductscience.org/library/papers/15738952 | PubMed |
| 19 | 3437792 | Immunoglobulin on the surface of isolated hepatocytes is associated with antibody-dependent cell-mediated cytotoxicity and liver damage. | Liver | 1987 | https://conductscience.org/library/papers/3437792 | PubMed |
| 20 | 18832247 | Hepatitis B virus infection. | N Engl J Med | 2008 | https://conductscience.org/library/papers/18832247 | PubMed |
Cited by3
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 5 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 35288624 | Natural antibody IgG levels are associated with HBeAg-positivity and seroconversion in chronic hepatitis B patients treated with entecavir. | Sci Rep | 2022 | https://conductscience.org/library/papers/35288624 | PubMed |
| 34578441 | Challenges in the Application of Glyco-Technology to Hepatitis B Virus Therapy and Diagnosis. | Viruses | 2021 | https://conductscience.org/library/papers/34578441 | PubMed |
| 30469416 | Fucosyl-Agalactosyl IgG₁ Induces Cholangiocarcinoma Metastasis and Early Recurrence by Activating Tumor-Associated Macrophage. | Cancers (Basel) | 2018 | https://conductscience.org/library/papers/30469416 | PubMed |
Genes10
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| CD19 | 930 | PubTator's text mining | https://conductscience.org/library/genes/930 | NCBI Gene |
| CD40 | 958 | PubTator's text mining | https://conductscience.org/library/genes/958 | NCBI Gene |
| CD8A | 925 | PubTator's text mining | https://conductscience.org/library/genes/925 | NCBI Gene |
| IFNA1 | 3439 | PubTator's text mining | https://conductscience.org/library/genes/3439 | NCBI Gene |
| IFNG | 3458 | PubTator's text mining | https://conductscience.org/library/genes/3458 | NCBI Gene |
| IL10 | 3586 | PubTator's text mining | https://conductscience.org/library/genes/3586 | NCBI Gene |
| IL2 | 3558 | PubTator's text mining | https://conductscience.org/library/genes/3558 | NCBI Gene |
| IL4 | 3565 | PubTator's text mining | https://conductscience.org/library/genes/3565 | NCBI Gene |
| MBL2 | 4153 | PubTator's text mining | https://conductscience.org/library/genes/4153 | NCBI Gene |
| SLC17A5 | 26503 | PubTator's text mining | https://conductscience.org/library/genes/26503 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/28512353
GET https://conductscience.org/api/papers/v1/28512353/references?page=2